NEW YORK (GenomeWeb News) — Clinical Data today said it has acquired privately held Epidauros Biotechnologie for €8.7 million ($11.8 million) in cash to help flesh out its pharmacogenomics abilities.
 
Clinical Data said it bought Epidauros for its portfolio of genetic biomarkers, expertise in genetic biomarker discovery, relationships with “leading” diagnostic companies, and its “fast-growing” pharmacogenomics services business.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.